Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial

The Lancet - Tập 353 Số 9151 - Trang 455-458 - 1999
Anthony J. Cleare1, Emma Heap2, Gin S. Malhi2, Simon Wessely1, Veronica O’Keane2, J P Miell3
1Department of Psychological Medicine, Guy's King's and St Thomas' School of Medicine and the Institute of Psychiatry, London SE5 8AF, UK
2Addenbrookes NHS Trust, Cambridge
3Department of Medicine, Guy's King's and St Thomas' School of Medicine and the Institute of Psychiatry, London SE5 8AF, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Wessely, 1997, The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study, Am J Public Health, 87, 1449, 10.2105/AJPH.87.9.1449

Vercoulen, 1996, Prognosis in chronic fatigue syndrome: a prospective study on the natural course, J Neurol Neurosurg Psychiatry, 60, 489, 10.1136/jnnp.60.5.489

David, 1991, Postviral fatigue syndrome and psychiatry, Brit Med Bull, 47, 966, 10.1093/oxfordjournals.bmb.a072524

Wearden, 1998, A double-blind, placebo controlled treatment trial of fluoxetine and a graded exercise programme for chronic fatigue syndrome, Br J Psychiatry, 172, 485, 10.1192/bjp.172.6.485

Vercoulen, 1996, Fluoxetine in chronic fatigue syndrome: a randomized, double-blind, placebo-controlled study, Lancet, 347, 858, 10.1016/S0140-6736(96)91345-8

Fulcher, 1997, Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome, BMJ, 314, 1647, 10.1136/bmj.314.7095.1647

Deale, 1997, A randomised controlled trial of cognitive behaviour versus relaxation therapy for chronic fatigue syndrome, Am J Psychiatry, 154, 408, 10.1176/ajp.154.3.408

Sharpe, 1996, Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial, BMJ, 312, 22, 10.1136/bmj.312.7022.22

Demitrack, 1991, Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome, J Clin Endocrinol Metab, 73, 1224, 10.1210/jcem-73-6-1224

Cleare, 1995, Contrasting neuroendocrine responses in depression and chronic fatigue syndrome, J Affect Disord, 35, 283, 10.1016/0165-0327(95)00026-J

Dinan, 1994, Glucocorticoids and the genesis of depressive illness: a psychobiological model, Br J Psychiatry, 164, 365, 10.1192/bjp.164.3.365

Scott, 1998, Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers, J Affect Disord, 47, 49, 10.1016/S0165-0327(97)00101-8

Leese, 1996, Short-term night-shift working mimics the pituitary-adrenocortical dysfunction of chronic fatigue syndrome, J Clin Endocrinol Metab, 81, 1867

Sharpe, 1997, A mind-body approach to functional somatic symptoms—the example of chronic fatigue, 169

Sharpe, 1991, Chronic fatigue syndrome: guidelines for research, J R Soc Med, 84, 118, 10.1177/014107689108400123

Fukuda, 1994, The chronic fatigue syndrome: a comprehensive approach to its definition and study, Ann Intern Med, 121, 953, 10.7326/0003-4819-121-12-199412150-00009

Tanaka, 1997, Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay, J Clin Endocrinol Metab, 82, 1440

Sharpe, 1997, Chronic fatigue syndrome: a practical guide to assessment and management, Gen Hosp Psychiatry, 19, 185, 10.1016/S0163-8343(97)80315-5

Besser, 1995

Chalder, 1993, Development of a fatigue scale, J Psychosom Res, 37, 147, 10.1016/0022-3999(93)90081-P

Pawlikowska, 1994, A population based study of fatigue and psychological distress, BMJ, 308, 743, 10.1136/bmj.308.6931.763

Guy, 1976, 76

Wittenborn, 1979, Somatic discomforts among depressed women, Arch Gen Psychiatry, 36, 465, 10.1001/archpsyc.1979.01780040107012

Howlett, 1997, An assessment of optimal hydrocortisone replacement therapy, Clin Endocrinol Oxf, 46, 263, 10.1046/j.1365-2265.1997.1340955.x

Wilson, 1994, Longitudinal study of the outcome of chronic fatigue syndrome, BMJ, 308, 756, 10.1136/bmj.308.6931.756

McKenzie, 1998, Low-dose hydrocortisone treatment of chronic fatigue syndrome: results of a placebo controlled study of its efficacy and safety, JAMA, 280, 1061, 10.1001/jama.280.12.1061

Barron, 1985, Hypothalamic dysfunction in overtrained athletes, J Clin Endocrinol Metab, 60, 803, 10.1210/jcem-60-4-803

Lehmann, 1992, Training-overtraining: performance, and hormone levels, after a defined increase in training volume versus intensity in experienced middle- and long-distance runners, Br J Sports Med, 26, 233, 10.1136/bjsm.26.4.233